comparemela.com

Latest Breaking News On - Genentech inc - Page 8 : comparemela.com

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update | Company Announcement

Genentech, Inc v Sandoz, Inc - Esbriet® (Pirfenidone) | Robins Kaplan LLP

Case Name: Genentech, Inc. v. Sandoz, Inc., Civ No. 23-4085 (JXN)(LDW), 2024 WL 939692 (D.N.J. Mar. 5, 2024) (Wettre, M.J.) - Drug Product and Patent(s)-in-Suit: Esbriet® (pirfenidone);.

vimarsana © 2020. All Rights Reserved.